BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
McKesson
Accenture
Colorcon
Mallinckrodt
US Department of Justice
Federal Trade Commission
Julphar
Novartis

Generated: January 19, 2018

DrugPatentWatch Database Preview

PHENOXYBENZAMINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Phenoxybenzamine Hydrochloride, and what generic alternatives are available?

Phenoxybenzamine Hydrochloride is a drug marketed by Par Pharm Inc and West-ward Pharms Int and is included in two NDAs.

The generic ingredient in PHENOXYBENZAMINE HYDROCHLORIDE is phenoxybenzamine hydrochloride. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the phenoxybenzamine hydrochloride profile page.
Drug patent expirations by year for PHENOXYBENZAMINE HYDROCHLORIDE
Pharmacology for PHENOXYBENZAMINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for PHENOXYBENZAMINE HYDROCHLORIDE

US Patents and Regulatory Information for PHENOXYBENZAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm Inc PHENOXYBENZAMINE HYDROCHLORIDE phenoxybenzamine hydrochloride CAPSULE;ORAL 204522-001 Jan 24, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int PHENOXYBENZAMINE HYDROCHLORIDE phenoxybenzamine hydrochloride CAPSULE;ORAL 201050-001 Jul 16, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Julphar
Federal Trade Commission
Covington
Farmers Insurance
AstraZeneca
US Department of Justice
Baxter
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot